EVARF

Lombard Medical, Inc.

 
Ordinary Shares SEC Reporting - Current
OTCQX International
Verified Company Profile 11/08/2017
Contact Info
  • Lombard Medical House
  • 4 Trident Park
  • Didcot, ENG OX11 7HJ
  • United Kingdom

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 20-F
CIK 0001597426
Fiscal Year End 12/31
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 3841 - Surgical and medical instruments
Incorporated In: Cayman Islands
Year of Inc. 2014
Employees 80 a/o Oct 31, 2017
Company Officers/Contacts
Kurt Lemvigh CEO
Peter Phillips CTO
Company Directors
Raymond Cohen Chairman
Michael H. Carrel
Jonathan Chen
John Rush
HongBin Sun
Service Providers
OTCQX Advisor
Not Available
Accounting/Auditing Firm
Baker Tilly Virchow Krause, LLP
225 South 6th Street
Suite 2300
Minneapolis, MN, 55402
United States

Legal Counsel
Jones Day
2727 N. Harwood St.
Suite 600
Dallas, TX, 75201
United States

Investor Relations Firm
Not Available
EVARF Security Details
Share Structure
Market Value1 $5,590,157 a/o Nov 21, 2017
Authorized Shares 100,000,000 a/o Nov 06, 2017
Outstanding Shares 27,950,785 a/o Nov 06, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,017,132 a/o Nov 06, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Computershare
Shareholders
Shareholders of Record Not Available
Short Selling Data
Short Interest (%)
Significant Failures to Deliver No

1Market Value calculated only for respective security